Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
As more states repeal or restrict abortion laws, the number of patients, the number of workers needed, and the cost of heart disease will increase. How should hospitals and policy makers prepare?
Read Full NewsThe rheumatology month in review emphasizes new data presented at the 2025 ACR Convergence.
A compilation of 13 trials presented as late-breaking data at ACR Convergence 2025.
New research at ACR 2025 highlights the link between cognitive impairment and disease activity in SLE.
Explore groundbreaking advancements in healthcare as 2025 concludes, featuring expert insights and dynamic multimedia.
This rheumatology month in review emphasizes new data from the ACR Convergence.
New data support firsekibart's efficacy over colchicine for preventing acute gout flares.
A new study reveals ligdolinurad effectively lowers uric acid levels in gout patients, showcasing promising safety and tolerability results.
1.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
2.
Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.
3.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
4.
New protein target discovered for childhood medulloblastomas
5.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
1.
Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
4.
Improving TIVAP Use: Review of Standardization and Optimization Practices
5.
Unlocking the Potential of Polatuzumab for Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part V
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
3.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Updates on Standard V/S High Risk Myeloma Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge